Change in vascular adhesion protein-1 and metabolic phenotypes after vertical banded gastroplasty for morbid obesity

Obesity Research

Volumn 13, Issue 5, 2005, Pages 855-861

  Li, Hung Yuan ^a   Lee, Wei Jei ^b   Chen, Mei Ju ^a   Chuang, Lee Ming ^a,c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b EN CHU KONG HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Blood pressure; Central obesity; Morbid obesity; Semicarbazide sensitive amine oxidase; Weight reduction

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); AOC3 PROTEIN, HUMAN; CELL ADHESION MOLECULE; INSULIN;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS; DIASTOLE; DIET RESTRICTION; FEMALE; GASTROPLASTY; GLUCOSE BLOOD LEVEL; HUMAN; MALE; MIDDLE AGED; MORBID OBESITY; PATHOPHYSIOLOGY; PHENOTYPE; REGRESSION ANALYSIS; VISCERA; WAIST HIP RATIO;

ADOLESCENT; ADULT; AMINE OXIDASE (COPPER-CONTAINING); ANALYSIS OF VARIANCE; BLOOD GLUCOSE; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS INDEX; CELL ADHESION MOLECULES; DIASTOLE; FASTING; FEMALE; GASTROPLASTY; HUMANS; INSULIN; MALE; MIDDLE AGED; OBESITY, MORBID; PHENOTYPE; REGRESSION ANALYSIS; VISCERA; WAIST-HIP RATIO;

EID: 24344508645     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2005.98     Document Type: Article

References (36)

1. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999;282:1523-9.
2. Allison DB, Fontaine KR, Manson JE, Stevens J, VanItallie TB. Annual deaths attributable to obesity in the United States. JAMA. 1999;284:1530-8.
3. Calle EE, Thun MJ, Petrelli JM, Rodruguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999;341:1097-105.
4. Lyon CJ, Law RE, Hsueh WA. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology. 2003;144:2195-200.
5. Lin WH, Tai TY, Wang PH, Chuang LM. Identification of differentially expressed genes during adipocyte differentiation and the effect of rosiglitazone on adipocyte gene expression. J Genet Mol Genet. 2002;13:28-43.
6. Salmi M, Jalkanen S. A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science. 1992;257:1407-9.
7. Salmi M, Jalkanen S. VAP-1: an adhesin and an enzyme. Trends Immunol. 2001;22:211-6.
8. Koutroubakis IE, Petinaki E, Vardas E, et al. Circulating soluble vascular adhesion protein 1 in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2002;14: 405-8.
9. Kurkijarvi R, Yegutkin GG, Gunson BK, Jalkanen S, Salmi M, Adams DH. Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease. Gastroenterology. 2000;119:1096-103.
10. Kurkijarvi R, Adams DH, Leino R, Mottonen T, Jalkanen S, Salmi M. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases. J Immunol. 1998;161:1549-57.
11. Salmi M, Stolen C, Jousilahti P, et al. Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes. Am J Pathol. 2002;161:2255-62.
12. Stolen CM, Yegutkin GG, Kurkijarvi R, Bono P, Alitalo K, Jalkanen S. Origins of serum semicarbazide-sensitive amine oxidase. Cire Res. 2004;95:50-7.
13. Abella A, Garcia-Vicente S, Viguerie N, et al. Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner. Diabetologia. 2004:47:429-38.
14. Boomsma F, Bhaggoe UM, van der Houwen AM, van den Meiracker AH. Plasma semicarbazide-sensitive amine oxidase in human (patho)physiology. Biochim Biophys Acta. 2003;1647:48-54.
15. Mercier N, Moldes M, El HK, Feve B. Semicarbazide-sensitive amine oxidase activation promotes adipose conversion of 3T3-L1 cells. Biochem J. 2001;358:335-42.
16. Bono P, Salmi M, Smith DJ, Jalkanen S. Cloning and characterization of mouse vascular adhesion protein-1 reveals a novel molecule with enzymatic activity. J Immunol. 1998:160:5563-71.
17. Garpenstrand H, Ekblom J, Backlund LB, Oreland L, Rosenqvist U. Elevated plasma semicarbazide-sensitive amine oxidase (SSAO) activity in type 2 diabetes mellitus complicated by retinopathy. Diabet Med. 1999;16:514-21.
18. Boomsma F, van den Meiracker AH, Winkle S, et al. Circulating semicarbazide-sensitive amine oxidase is raised both in type I (insulin-dependent), in Type II (non-insulin-dependent) diabetes mellitus and even in childhood type I diabetes at first clinical diagnosis. Diabetologia. 1999;42:233-7.
19. Meszaros Z, Szombathy T, Raimondi L, Karadi I, Romics L, Magyar K. Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: correlation with body mass index and serum triglycéride. Metabolism. 1999;48:113-7.
20. Nilsson SE, Trydin N, Tufvesson G. Serum monoamine oxidase in diabetes mellitus and some other internal diseases. Acta Med Scand. 1968;184:105-8.
21. Boomsma F, de Kam PJ, Tjeerdsma G, van den Meiracker AH, van Veldhuisen DJ. Plasma semicarbazide-sensitive amine oxidase (SSAO) is an independent prognostic marker for mortality in chronic heart failure. Eur Heart J. 2000;21:1859-63.
22. Gokturk C, Nilsson J, Nordquist J, et al. Overexpression of semicarbazide-sensitive amine oxidase in smooth muscle cells leads to an abnormal structure of the aortic elastic laminas. Am J Pathol. 2003;163:1921-8.
23. Consensus Development Conference Statement Gastrointestinal surgery for severe obesity. Ann Intern Med. 1991;115:956.
24. Inoue S, Zimmet P, Caterson I, et al. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Melbourne, Australia: Health Communications Australia Pty.; 2000.
25. Chen KM, Lee WJ, Lai HS, Chen WJ. Fifteen years' experience with gastric partitioning for obesity treatment. J Formos Med Assoc. 1998;97:381-6.
26. Pei D, Jones CNO, Bhargava R, Chen Y-DI, Reaven GM. Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test. Diabetologia. 1994;37: 843-5.
27. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
28. Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Björntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J. 1984;288:1401-4.
29. Lapidus L, Bengtsson C, Larsson B, Pennert K, Elisabeth R, Sjöström L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J. 1984;289:1257-61.
30. Sowers JR. Obesity as a cardiovascular risk factor. Am J Med. 2003;115:37-418.
31. Dowling HJ, Pi-Sunyer FX. Race-dependent health risks of upper body obesity. Diabetes. 1993;42:537-43.
32. Langford SD, Trent MB, Balakumaran A, Boor PJ. Developmental vasculotoxicity associated with inhibition of semicarbazide-sensitive amine oxidase. Toxicol Appl Pharmacol. 1999;155:237-44.
33. Bonithon-Kopp C, Raison J, Courbon D, Bonhomme G, Guy-Grand B, Ducimetiere P. Relationships between 3-y longitudinal changes in body mass index, waist-to-hip ratio, and metabolic variables in an active French female population. Am J Clin Nutr. 1992;56:475-82.
34. Ahmad F, Azevedo JLJ, Cortright R, Dohm GL, Goldstein BJ. Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. J Clin Invest. 1997;100:449-58.
35. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001;414:799-806.
36. Abella A, Marti L, Camps M, et al. Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 activity exerts an antidiabetic action in Goto-Kakizaki rats. Diabetes. 2003;52:1004-13.